Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.68% |
| 2 | Technology | 12.88% |
| 3 | Consumer Staples | 9.84% |
| 4 | Communication Services | 9.02% |
| 5 | Financials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VAR
1601
DELISTED
Varian Medical Systems, Inc.
VAR
| $4.75M | ﹤0.01% |
46,300
-273,054
| -86% | -$36.1M |
|
|
KIN
1602
DELISTED
Kindred Biosciences, Inc.
KIN
| $4.73M | ﹤0.01% |
1,182,898
+3,600
| +0.3% | +$30.6K |
|
1603
Twilio
TWLO
$36.6B
| $4.72M | ﹤0.01% |
+52,795
| New | +$5.8M |
|
1604
Shore Bancshares
SHBI
$800M
| $4.71M | ﹤0.01% |
434,600
-27,753
| -6% | -$405K |
|
1605
Horace Mann Educators
HMN
$2.13B
| $4.71M | ﹤0.01% |
128,800
+2,300
| +2% | +$94.9K |
|
|
KE
1606
Kimball Electronics
KE
$622M
| $4.7M | ﹤0.01% |
430,575
+2,200
| +0.5% | +$32.8K |
|
1607
Ribbon Communications
RBBN
$377M
| $4.7M | ﹤0.01% |
1,550,800
-328,800
| -17% | -$988K |
|
1608
TechnipFMC
FTI
$30.8B
| $4.68M | ﹤0.01% |
+934,214
| New | +$10.3M |
|
1609
AC Immune
ACIU
$253M
| $4.68M | ﹤0.01% |
677,311
+189,909
| +39% | +$1.48M |
|
|
CMRX
1610
DELISTED
Chimerix, Inc.
CMRX
| $4.68M | ﹤0.01% |
3,250,013
+295,877
| +10% | +$518K |
|
|
ECHO
1611
DELISTED
Echo Global Logistics, Inc.
ECHO
| $4.67M | ﹤0.01% |
273,400
-48,400
| -15% | -$943K |
|
|
AMNB
1612
DELISTED
American National Bankshares Inc
AMNB
| $4.65M | ﹤0.01% |
194,400
-2,641
| -1% | -$85.8K |
|
1613
Lennar Class B
LEN.B
$20.6B
| $4.64M | ﹤0.01% |
168,653
+997
| +0.6% | +$43.6K |
|
|
PZN
1614
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $4.63M | ﹤0.01% |
1,038,900
+24,799
| +2% | +$174K |
|
|
OXFD
1615
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $4.61M | ﹤0.01% |
497,300
+81,500
| +20% | +$1.14M |
|
|
RPT
1616
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $4.6M | ﹤0.01% |
763,202
+342,102
| +81% | +$4.28M |
|
1617
Nature's Sunshine
NATR
$266M
| $4.6M | ﹤0.01% |
565,497
+3,359
| +0.6% | +$30.4K |
|
|
AGTC
1618
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $4.59M | ﹤0.01% |
1,398,709
+184,369
| +15% | +$971K |
|
|
MRSN
1619
DELISTED
Mersana Therapeutics
MRSN
| $4.57M | ﹤0.01% |
31,343
+2,552
| +9% | +$446K |
|
|
CHK
1620
DELISTED
Chesapeake Energy Corporation
CHK
| $4.56M | ﹤0.01% |
+131,949
| New | +$11.6M |
|
1621
Knowles
KN
$3.29B
| $4.56M | ﹤0.01% |
340,574
-216,100
| -39% | -$3.76M |
|
1622
Enerpac Tool Group
EPAC
$1.89B
| $4.55M | ﹤0.01% |
275,243
-408,450
| -60% | -$9.07M |
|
|
VRN
1623
DELISTED
Veren
VRN
| $4.55M | ﹤0.01% |
5,893,270
+2,940,343
| +100% | +$8.13M |
|
|
SEAC
1624
DELISTED
Seachange International Inc
SEAC
| $4.55M | ﹤0.01% |
61,132
-9,070
| -13% | -$693K |
|
|
ALTA
1625
DELISTED
Altabancorp
ALTA
| $4.54M | ﹤0.01% |
234,640
-1,600
| -0.7% | -$40K |
|
Similar funds
Jim Simons's Q1 2020 Portfolio in Review
As of Q1 2020, Jim Simons held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jim Simons's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Jim Simons added most to Baidu in Q1 2020, an estimated $462M increase.
- Jim Simons's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Jim Simons fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Jim Simons's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Jim Simons opened 573 new positions and closed 645 in Q1 2020.
- Jim Simons's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.